Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116813544B reveals catalyst-free heating method. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing globally with green chemistry.
Novel radical cyclization method for high-purity phenanthridine intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102766092A details a mild chiral spiro phosphoric acid catalyzed synthesis of optically active tetrahydroquinolines, offering high enantioselectivity and simplified purification for API manufacturing.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. Reduces cost in API manufacturing via safe CO sources and cheap nitro substrates.
Patent CN111978194B details a novel Pd-catalyzed carbonylation using benzyl formate. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN102180755A details a green synthesis of aryl azides using cuprous oxide in water. This method offers significant cost reduction and safety advantages for pharmaceutical manufacturing.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Novel palladium-catalyzed synthesis offers mild conditions and high efficiency. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Novel quinoline-substituted ligand enables high ee asymmetric trifluoromethylation. Cost-effective synthesis for pharmaceutical intermediate manufacturing supply chain.
Novel Pd-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed method for (iso)chroman amides using nitroarenes. High yield, scalable process for reliable pharmaceutical intermediate supply.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO surrogate. Enhances safety and yield for API intermediates.
Advanced Cu-catalyzed synthesis of 1-substituted-1,2,3-triazoles from patent CN101792438B. Offers high purity, scalable routes for pharmaceutical intermediates and cost-effective manufacturing solutions.
Patent CN113045503B discloses a novel Pd-catalyzed carbonylation for 2-CF3 quinazolinones. High-yield, scalable route for API intermediates like Rutaecarpine.
Patent CN113105402B reveals a metal-free iodine-promoted route for 1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109096139B discloses a novel metal-free method for preparing alpha-carbonyl amides using water as an oxygen source, offering significant cost and purity advantages for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis for azaspiro tetraenone compounds. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.